# Trofinetide

**Source:** https://www.startuphub.ai/startups/trofinetide
**Profile type:** Startup

> Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

## About

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for central nervous system (CNS) disorders. Their key product, DAYBUE® (trofinetide), is the first and only FDA-approved drug for the treatment of Rett syndrome in adult and pediatric patients two years of age and older. Acadia has expanded its global reach for trofinetide through licensing agreements and continues to advance its pipeline for other neurological conditions.

## Key facts

- **Slug:** trofinetide
- **Website:** https://trofinetide.xyz
- **Founded:** 2026-06-08
- **Employees:** 1032
- **Operating status:** Active
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Neuroscience
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/acadia-pharmaceuticals
  - Twitter: https://x.com/acadiapharma

## Frequently asked

### What does Trofinetide do?

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for central nervous system (CNS) disorders. Their key product, DAYBUE® (trofinetide), is the first and only FDA-approved drug for the treatment of Rett syndrome in adult and pediatric patients two years of age and older. Acadia has expanded its global reach for trofinetide through licensing agreements and continues to advance its pipeline for other neurological conditions.

### What is Trofinetide's Effective Domain Rating?

StartupHub's Effective Domain Rating for Trofinetide is 89 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 70, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.

### Is Trofinetide trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Trofinetide is 92 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

### What is Trofinetide's revenue?

StartupHub estimates Trofinetide's annual revenue at $98.9M (range $60.0M to $337.4M, 68% confidence), based on comparable companies in the sector.

### When was Trofinetide founded?

Trofinetide was founded in 2026.

### What industry does Trofinetide operate in?

Trofinetide operates in Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Neuroscience.

### How many employees does Trofinetide have?

Trofinetide has approximately 1032 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Trofinetide",
          "item": "https://www.startuphub.ai/startups/trofinetide"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/trofinetide#webpage",
      "url": "https://www.startuphub.ai/startups/trofinetide",
      "name": "Trofinetide - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Trofinetide. Trofinetide is a startup founded in 2026, operating in Biotechnology and Pharmaceuticals. Develops and commercializes treatments for central nervous system disorders, including Rett syndrome. The company has approximately 1032 employees.",
      "dateModified": "2026-08-02T11:03:36.745+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/trofinetide#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/trofinetide#organization",
      "name": "Trofinetide",
      "url": "https://trofinetide.xyz",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/bc49ccec-195d-442b-9eee-fec1bce4e8b3-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/bc49ccec-195d-442b-9eee-fec1bce4e8b3-square.webp",
      "description": "This is the official profile of Trofinetide. Trofinetide is a startup founded in 2026, operating in Biotechnology and Pharmaceuticals. Develops and commercializes treatments for central nervous system disorders, including Rett syndrome. The company has approximately 1032 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/acadia-pharmaceuticals",
        "https://x.com/acadiapharma",
        "https://www.startuphub.ai/startups/trofinetide"
      ],
      "foundingDate": "2026-06-08",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 1032
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Drug Discovery",
        "HealthTech",
        "Neuroscience"
      ]
    }
  ]
}
```